EWIC, March 5-7, 2020

02/03/2020

Omixon is one of the Platinum Sponsors of the EWIC 2020 Conference being held in Budapest, Hungary. Visit our booth and join our talk, titled “Genome-wide Approaches for Identification of Disease-Associated Gene Variants: Base Concepts and Examples” on Friday, March 6 from 13:05! EWIC 2020 website

Holotype HLA v3.0.1 is now CE-IVD certified!

28/02/2020

Omixon is pleased to announce that the latest Holotype HLA protocol version (v3.0.1) has received a CE-IVD certificate that complies with the IVD Directive 98/79/EC allowing commercialization of the new version products as IVD in Europe. The new Holotype HLA v3.0.1 kit includes pre-mixed PCR amplification reagents that reduce...

Interview with the South African National Blood Service

28/02/2020

The following interview is part of our interview series that we are conducting with Key Opinion Leaders, Experts and Business Managers within the HLA field. This time Dr. Lavendri Govender and Dr. Ute Jentsch from South-African National Blood Service talk about their experiences and thoughts on technology improvements. We...

AGBT, February 23-26, 2020

24/02/2020

We are attending this year’s AGBT Conference in Marco Island, Florida! Read more about the event here and see our scientific poster here.

Announcement – First Omixon Shipment to Kazakhstan

24/02/2020

We are pleased to inform our customers that Omixon have now officially shipped the first Holotype HLA kits for commercial sale to Nur-Sultan, Kazakhstan with the help of our local partner, Dilen s.r.o., our exclusive distributor in the country. “Our national reach and full technical support is now...